O'Dell Group’s Zomedica Corp. ZOM Stock Holding History

O'Dell Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,000	Closed	-$2.04K	–	109
2024 Q4	$2.04K	Hold	17,000	–	–	﹤0.01%	106
2024 Q3	$2.33K	Hold	17,000	–	–	﹤0.01%	98
2024 Q2	$2.48K	Hold	17,000	–	–	﹤0.01%	90
2024 Q1	$2.48K	Hold	17,000	–	–	﹤0.01%	90
2023 Q4	$3.4K	Hold	17,000	–	–	﹤0.01%	419
2023 Q3	$2.84K	Hold	17,000	–	–	﹤0.01%	78
2023 Q2	$3.4K	Hold	17,000	–	–	﹤0.01%	412
2023 Q1	$3.6K	Hold	17,000	–	–	﹤0.01%	71
2022 Q4	$2.77K	Hold	17,000	–	–	﹤0.01%	75
2022 Q3	$4K	Hold	17,000	–	–	﹤0.01%	352
2022 Q2	$4K	Hold	17,000	–	–	﹤0.01%	368
2022 Q1	$6K	Hold	17,000	–	–	﹤0.01%	377
2021 Q4	$5K	Hold	17,000	–	–	﹤0.01%	401
2021 Q3	$9K	Hold	17,000	–	–	﹤0.01%	313
2021 Q2	$14K	Hold	17,000	–	–	﹤0.01%	81
2021 Q1	$27K	Sell	17,000 -3,000	-15%	-$4.9K	0.01%	72
2020 Q4	$5K	Buy	+20,000	New	+$2.55K	﹤0.01%	68

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $170M AUM 21.01% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

O'Dell Group's ZOM Position: Q1 2025 in Review

O'Dell Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 17,000 shares — an estimated $2.04K sold.

O'Dell Group first reported a position in ZOM in Q4 2020 and held it in 17 quarters. The position peaked at $27K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

O'Dell Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
O'Dell Group sold 17,000 Zomedica Corp. shares in Q1 2025, an estimated $2.04K.
O'Dell Group first reported a position in Zomedica Corp. in Q4 2020 and held it in 17 quarters.
O'Dell Group's Zomedica Corp. position peaked at $27K in Q1 2021.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on O'Dell Group's 13F filing for Q1 2025, filed 21 Apr 2025.